| 1 |
24084219 | Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension. | 2014 Jan |
1 |
| 2 |
22481098 | Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. | 2012 |
2 |
| 3 |
16391888 | Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus. | 2007 Apr |
2 |
| 4 |
10464856 | Acute effects of nebulised epoprostenol in pulmonary hypertension due to systemic sclerosis. | 1999 Feb |
1 |
| 5 |
9458458 | An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. | 1997 Sep |
3 |
| 6 |
7977706 | Kinetics of prostacyclin synthesis in PGHS-1-overexpressed endothelial cells. | 1994 Nov |
1 |
| 7 |
8473524 | Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA. | 1993 Apr |
1 |
| 8 |
3311362 | Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin. | 1987 Jan |
1 |
| 9 |
3325091 | Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man. | 1987 Nov |
1 |
| 10 |
3912001 | Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin. | 1985 Dec |
2 |
| 11 |
6197766 | Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. | 1983 Nov 15 |
1 |
| 12 |
6362696 | The effect of intravenous epoprostenol (prostacyclin, PGI2) on cerebral blood flow and cardiac output in man. | 1983 Dec |
1 |
| 13 |
6105392 | Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. | 1980 Aug 2 |
1 |